Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Lutz Muller"'
Autor:
Martin Bornhauser, Christoph Schliemann, Johannes Schetelig, Christoph Röllig, Michael Kramer, Bertram Glass, Uwe Platzbecker, Andreas Burchert, Mathias Hänel, Lutz Muller, Stefan Klein, Gesine Bug, Dietrich Beelen, Wolf Rösler, Kerstin Schäfer-Eckart, Christoph Schmid, Edgar Jost, Georg Lenz, Johanna Tischer, Karsten Spiekermann, Markus Pfirrmann, Hubert Serve, Friedrich Stölzel, Nael Alakel, Jan Moritz Middeke, Christian Thiede, Gerhard Ehninger, Wolfgang Berdel, Matthias Stelljes
The ideal post-remission strategy in patients with intermediate-risk (IR) acute myeloid leukemia (AML) in first complete remission (CR) has been a matter of debate. To address this question, one hundred and forty-three patients with AML, IR cytogenet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2436dd4e645fe736a48fa1850a5ded0
https://doi.org/10.21203/rs.3.rs-1820408/v1
https://doi.org/10.21203/rs.3.rs-1820408/v1
Autor:
Stefanie Kewitz‐Hempel, Nicola Windisch, Gerd Hause, Lutz Müller, Cord Sunderkötter, Dennis Gerloff
Publikováno v:
Journal of Extracellular Vesicles, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract In melanoma, carcinoma‐associated fibroblasts (CAFs) are important cellular components in the tumour microenvironment due to their potential to promote tumour growth and metastatic spread of malignant cells. Melanoma cells have the ability
Externí odkaz:
https://doaj.org/article/afe2576122cf4d9bb5cab3b1c6a9657c
Autor:
Michallet, Mauricette, Dreger, Peter, Sobh, Mohamad, Koster, Linda, Hoek, Jennifer, Boumendil, Ariane, Scheid, Christof, Fox, Christopher P, Wulf, Gerald, Krüger, William, van Gelder, Michel, Corradini, Paolo, Russo, Domenico, Passweg, Jakob, Schoemans, Hélène, Bethge, Wolfgang, Schaap, Nicolaas, Cornelissen, Jan, Browne, Paul, Duraković, Nadira, Lutz, Muller, Montoto, Silvia, Kroger, Nicolaus, Schetelig, Johannes
The purpose of our study is to provide information on safety and efficacy of ibrutinib as salvage treatment after allo-HSCT for CLL. A total of 56 patients were included, 36 (64%) males ; median age at transplantation was 48 years (range: 35–64) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::bb739803e6b2c9c41652056d7fccd53f
https://www.bib.irb.hr/1194290
https://www.bib.irb.hr/1194290
Autor:
Lutz Muller
Neste primeiro volume da Biblioteca Psicologia e Mito, o analista junguiano Lutz Müller revela o verdadeiro caminho do herói o caminho da individuação e da vida criativa, o caminho da mudança que, através do enfrentamento da morte, leva a uma n
Autor:
Nicolaus Kröger, Gerald Wulf, Ute Hegenbart, Andreas Burchert, Matthias Stelljes, Nico Gagelmann, Arne Brecht, Martin Kaufmann, Lutz Müller, Arnold Ganser, Dominik Wolf, Wolfgang Bethge, Martin Bornhäuser, Michael Kiehl, Eva-Maria Wagner, Christoph Schmid, Hans Christian Reinhardt, Guido Kobbe, Hans Salwender, Thomas Heinicke, Martin Kropff, Marion Heinzelmann, Francis Ayuk, Lorenz Trümper, Andreas Neubauer, Andreas Völp, Evgeny Kluychnikov, Stefan Schönland, Christine Wolschke
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
The role of autologous-allogeneic tandem stem cell transplantation (alloTSCT) followed by maintenance as upfront treatment for multiple myeloma is controversial. Between 2008 and 2014 a total of 217 multiple myeloma patients with a median age of 51 y
Externí odkaz:
https://doaj.org/article/d16b172f3b0d40de80f3b187f9e3c4b7
Autor:
Pai Lu, Martin Hoffmann, Kang Du, Xuyuan Chen, Lutz Muller, Mika Prunnila, Jouni Ahopelto, Per Ohlckers, Einar Halvorsen, Kestutis Grigoras, Steffen Leopold
Publikováno v:
Lu, P, Du, K, Ohlckers, P, Halvorsen, E, Müller, L, Leopold, S, Hoffmann, M, Grigoras, K, Ahopelto, J, Prunnila, M & Chen, X 2017, Silicon grass based nano functional electrodes for MEMS supercapacitors of improved energy density . in 2017 19th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS) ., 7994425, IEEE Institute of Electrical and Electronic Engineers, pp. 1828-1831, 19th International Conference on Solid-State Sensors, Actuators and Microsystems, TRANSDUCERS 2017, Kaohsiung, Taiwan, Province of China, 18/06/17 . https://doi.org/10.1109/TRANSDUCERS.2017.7994425
Nano-structure functional electrodes for high energy density MEMS supercapacitors have been fabricated by combining atomic layer deposition (ALD) and cyclic deep reactive ion etch (C-DRIE) in MEMS technology. The electrodes were structured with C-DRI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7613df993428023d07b0f4cc4c6dc6f4
https://cris.vtt.fi/en/publications/ae8b563a-4096-465d-a768-b16d8f28ea7c
https://cris.vtt.fi/en/publications/ae8b563a-4096-465d-a768-b16d8f28ea7c
Autor:
Marcos Lutz Muller
Publikováno v:
DoisPontos, Vol 3, Iss 2, Pp 11-28 (2006)
After a brief reminiscence of Gerd Bornheim's intellectual and personal trajectory (I), I emphasize the originality of his interpretation of Sartre's phenomenological ontology, focused on the theme of the "crisis of grounding", read through the Heide
Publikováno v:
ICINCO (2)
One of the most important concepts in an automotive production process is that of a manufacturing sequence. Sequencing has a vital influence on a series of important performance indicators such as load balance, setup time, setup cost, timeliness, flo
Autor:
Mauricette Michallet, Nicola Mordini, Hélène Schoemans, Johannes Schetelig, Mohamad Sobh, Nicolaus Kröger, Nicolaas Schaap, Domenico Russo, Dietger Niederwieser, Tobias Berg, Ilaria Scortechini, Peter Dreger, Jennifer Hoek, Jürgen Finke, Wolfgang Bethge, Lutz Muller, Jakob Passweg, Michel van Gelder, Hélène Labussière, Ariane Boumendil, Niels Smedegaard Andersen, Nadira Duraković, Silvia Montoto, Elisabeth Vandenberghe
Publikováno v:
ResearcherID
BACKGROUND: The advent of the Bruton's tyrosine kinase inhibitor ibrutinib has improved the outlook of patients with CLL and MCL failing chemoimmunotherapy (CIT). However, the impact of ibrutinib on the feasibility and safety of a subsequent alloHCT
Autor:
Paolo Corradini, Michel van Gelder, Nicolaas Schaap, Jennifer Hoek, Nicolaus Kröger, Mohamad Sobh, Johannes Schetelig, Mauricette Michallet, Lutz Muller, Wolfgang Bethge, Nadira Duraković, Ariane Boumendil, Domenico Russo, Peter Dreger
Publikováno v:
ResearcherID
BACKGROUND: Allo-HSCT is an accepted treatment option for patients with relapsed and refractory B cell lymphomas or high-risk chronic lymphocytic leukemia (CLL). This treatment option is currently reshaped by the introduction of pathway inhibitors (P